NEW YORK — In an unprecedented move that will redefine the American healthcare system, major insurers have officially begun denying claims for patients who exhibit “predictive anxiety” about developing conditions that have not yet manifested. According to the newly released 2026 Prior Authorization Guidelines, insurance companies are now justified in refusing coverage for individuals who:

  • Have been diagnosed with a genetic predisposition to certain cancers but have never tested positive
  • Experience “anticipatory worry” about developing rare conditions
  • Ask questions that demonstrate they understand their own medical risks
  • Express concern about the very real possibility of falling ill

“This is a natural evolution of the healthcare system,” explained Dr. Jennifer Mordant of the National Institute of Insurance Innovation. “Why should we pay for services that might not be needed? Our new AI-powered denial algorithms can predict illness before the symptoms appear, and if the patient shows enough concern about the prediction, that’s sufficient evidence of need.”

The implications are staggering. Under the new regulations, a patient who experiences a single episode of health-related anxiety could find their insurance coverage for all future treatments suspended indefinitely. One patient, Mr. Harold Peterson, told me his insurance company denied his claim for a routine check-up after he asked a nurse at his doctor’s office whether he was “at risk” for a condition that had not been diagnosed in him.

“Every time I ask a question about my health, the system marks me as ‘at risk,’ and then denies my claim because I’m supposedly exhibiting predictive anxiety,” Peterson said. “My own fear of being sick has now been weaponized against me.”

Meanwhile, pharmaceutical companies have seized upon this regulatory shift with enthusiasm. According to a spokesperson for Merck’s new “Future Health Assurance” division: “Our new ‘predictive anxiety’ drug can now be marketed as a solution to the very conditions patients are denied coverage for. We call it ‘anxiety about anxiety.’” The drug, which costs $299,000 per dose and has no known active ingredients, is billed under CPT code 99998: “Treatment for Existential Financial Anxiety About Potential Future Illnesses.”

The FDA has also taken a hands-off approach to approving these new medications. In a rare press release, FDA Commissioner Dr. Harold “The Regulatory Ghost” Smith stated: “We believe patients should be allowed to pay their own way out of the existential dread that comes with not being able to afford necessary care. The current system is broken, and we’re moving toward a model where patients pay for their own medical insurance.”

Under the new “Self-Pay Freedom Act,” patients who cannot afford their medication can opt to receive treatment “as is,” without insurance coverage. One patient, Ms. Linda Chen, now works part-time at a fast-food restaurant to pay her way through a $450,000 year of “predictive anxiety treatment.” When asked why she chose to pay out-of-pocket rather than appeal her claim, Chen said: “At least I get to keep my dignity. The insurance companies say my anxiety is ’not medically necessary,’ but at least I can choose to be dignified while I wait for my claim to be denied.”

The industry is responding with even more bureaucratic innovation. Health systems are now billing for “consultation fees” for patients who call their insurance company to ask questions about their coverage. These consultations are billed at $1,500 per call, regardless of whether the insurance company representative can actually answer the question or has to transfer the patient to a different department.

One hospital system in California has taken the practice a step further, billing for “theoretical care” when a patient expresses concern about a condition that has not yet been diagnosed. The hospital’s billing department has developed a new CPT code: 99999, “Consultation for Uncertainty About Whether Patient Will Get Sucked Into Insurance Hell.”

The industry’s response to these challenges is to push for even more restrictive policies. The American Insurance Association has launched a new initiative called “Preventative Denial,” which will use AI to identify patients who are “at risk” of becoming high-risk customers. Once flagged, their insurance premiums will increase automatically, regardless of their actual medical status.

This marks a new era in American healthcare, where patients are not just denied care based on their current health status, but also based on their anxiety about the future. As the system continues to evolve, one thing is clear: the American healthcare industry has found a new way to monetize the human condition itself. The only thing more bureaucratic than healthcare billing is the bureaucracy of healthcare bureaucracy itself.

This article was fact-checked by a former insurance company claims adjuster who no longer works in the industry because he now receives threats of denial from three different carriers.